Berzi A[Author] - Search Results

Year	Number of Results
1973	1
2008	1
2010	1
2012	1
2013	1
2014	3
2015	2
2016	3
2017	2
2022	0

1

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, Tuccitto A, Tagliabue E, Castelli C, Rivoltini L. Huber V, et al. Among authors: berzi a. Semin Cancer Biol. 2017 Apr;43:74-89. doi: 10.1016/j.semcancer.2017.03.001. Epub 2017 Mar 6. Semin Cancer Biol. 2017. PMID: 28267587 Free article. Review.

2

Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants.

Berzi A, Ordanini S, Joosten B, Trabattoni D, Cambi A, Bernardi A, Clerici M. Berzi A, et al. Sci Rep. 2016 Oct 13;6:35373. doi: 10.1038/srep35373. Sci Rep. 2016. PMID: 27734954 Free PMC article.

3

Cranial anatomy of oreopithecus.

Szalay FS, Berzi A. Szalay FS, et al. Among authors: berzi a. Science. 1973 Apr 13;180(4082):183-5. doi: 10.1126/science.180.4082.183. Science. 1973. PMID: 17811656

4

A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus.

Varga N, Sutkeviciute I, Ribeiro-Viana R, Berzi A, Ramdasi R, Daghetti A, Vettoretti G, Amara A, Clerici M, Rojo J, Fieschi F, Bernardi A. Varga N, et al. Among authors: berzi a. Biomaterials. 2014 Apr;35(13):4175-84. doi: 10.1016/j.biomaterials.2014.01.014. Epub 2014 Feb 6. Biomaterials. 2014. PMID: 24508075 Free article.

5

Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation.

Sattin S, Daghetti A, Thépaut M, Berzi A, Sánchez-Navarro M, Tabarani G, Rojo J, Fieschi F, Clerici M, Bernardi A. Sattin S, et al. Among authors: berzi a. ACS Chem Biol. 2010 Mar 19;5(3):301-12. doi: 10.1021/cb900216e. ACS Chem Biol. 2010. PMID: 20085340

6

Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design.

Sutkeviciute I, Thépaut M, Sattin S, Berzi A, McGeagh J, Grudinin S, Weiser J, Le Roy A, Reina JJ, Rojo J, Clerici M, Bernardi A, Ebel C, Fieschi F. Sutkeviciute I, et al. Among authors: berzi a. ACS Chem Biol. 2014 Jun 20;9(6):1377-85. doi: 10.1021/cb500054h. Epub 2014 May 6. ACS Chem Biol. 2014. PMID: 24749535

7

Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccines.

Berzi A, Varga N, Sattin S, Antonazzo P, Biasin M, Cetin I, Trabattoni D, Bernardi A, Clerici M. Berzi A, et al. Viruses. 2014 Jan 27;6(2):391-403. doi: 10.3390/v6020391. Viruses. 2014. PMID: 24473338 Free PMC article.

8

A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.

Berzi A, Reina JJ, Ottria R, Sutkeviciute I, Antonazzo P, Sanchez-Navarro M, Chabrol E, Biasin M, Trabattoni D, Cetin I, Rojo J, Fieschi F, Bernardi A, Clerici M. Berzi A, et al. AIDS. 2012 Jan 14;26(2):127-37. doi: 10.1097/QAD.0b013e32834e1567. AIDS. 2012. PMID: 22045343 Free article.

9

Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods.

Ordanini S, Varga N, Porkolab V, Thépaut M, Belvisi L, Bertaglia A, Palmioli A, Berzi A, Trabattoni D, Clerici M, Fieschi F, Bernardi A. Ordanini S, et al. Among authors: berzi a. Chem Commun (Camb). 2015 Mar 4;51(18):3816-9. doi: 10.1039/c4cc09709b. Chem Commun (Camb). 2015. PMID: 25648900 Free article.

10

Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption.

Pedotti R, Musio S, Scabeni S, Farina C, Poliani PL, Colombo E, Costanza M, Berzi A, Castellucci F, Ciusani E, Confalonieri P, Hemmer B, Mantegazza R, Antozzi C. Pedotti R, et al. Among authors: berzi a. J Neuroimmunol. 2013 Sep 15;262(1-2):19-26. doi: 10.1016/j.jneuroim.2013.05.010. Epub 2013 Jun 13. J Neuroimmunol. 2013. PMID: 23768729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results